UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
UTAH MEDICAL PRODUCTS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$74.55+0.04 (+0.05%)
Close on Oct 19, 2026
- Market cap
- $237.37M
- P/E (TTM)
- 22.7
- Dividend yield
- –
Utah Medical Products statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Market Cap | $237.35M | $229.23M |
| Enterprise Value | $150.02M | $194.73M |
| PE Ratio | 22.73 | 33.41 |
| PS Ratio | 6.57 | 3.14 |
| PB Ratio | 1.95 | 3.19 |
| P/TBV Ratio | 2.20 | 4.69 |
| P/FCF Ratio | 20.73 | 27.25 |
| P/OCF Ratio | 20.03 | 22.23 |
Enterprise value
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| EV / Sales | 4.15 | 2.93 |
| EV / EBITDA | 14.61 | 19.97 |
| EV / EBIT | 14.61 | 25.47 |
| EV / FCF | 13.11 | 27.85 |
Income (trailing twelve months)
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Revenue | $36.11M | $102.39M |
| Gross Profit | $20.91M | $60.36M |
| Operating Income | $10.27M | -$4.31M |
| Pretax Income | $12.88M | -$2.26M |
| EBITDA | $10.27M | -$1.98M |
| EPS (Diluted) | $3.28 | -$0.07 |
Margins
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Gross Margin | 57.9% | 55.1% |
| Operating Margin | 28.4% | -6.04% |
| Pretax Margin | 35.7% | -4.11% |
| EBITDA Margin | 28.4% | -2.67% |
| FCF Margin | 31.7% | -0.30% |
Returns
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Return on Invested Capital (ROIC) | 23.9% | -4.11% |
| Return on Capital Employed (ROCE) | 8.38% | -9.07% |
Growth
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -9.68% | 7.08% |
| Revenue Growth (5Y CAGR) | -1.80% | 11.8% |
| EPS Growth (3Y CAGR) | -8.35% | 3.06% |
| EPS Growth (5Y CAGR) | 3.43% | 7.64% |
Balance sheet
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $87.53M | $37.33M |
| Total Debt | $195.00K | $72.66M |
| Net Cash (Debt) | $87.33M | $3.92M |
| Net Cash Per Share | $27.43 | $0.28 |
| Equity (Book Value) | $122.03M | $57.36M |
| Book Value Per Share | $38.33 | $2.81 |
| Tangible Book Value | $107.73M | $10.71M |
| Working Capital | $98.57M | $54.64M |
Financial position
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Current Ratio | 48.62 | 2.50 |
| Quick Ratio | 44.01 | 1.54 |
| Debt / Equity | 0.00 | 0.38 |
| Debt / EBITDA | 0.02 | 2.31 |
| Debt / FCF | 0.02 | 3.50 |
| Net Debt / EBITDA | -8.51 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Operating Cash Flow | $11.85M | -$653.46K |
| Capital Expenditures | -$400.00K | -$3.69M |
| Free Cash Flow | $11.45M | -$835.02K |
| FCF Per Share | $3.60 | -$0.02 |
Efficiency
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Asset Turnover | 0.29 | 0.59 |
| Inventory Turnover | 1.76 | 2.21 |
| Revenue Per Employee | $257.91K | $322.75K |
| Employee Count | 140 | 197 |
Dividends and yields
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| FCF Yield | 4.82% | -0.62% |
| Buyback Yield | 0.78% | 0.78% |
| Shareholder Yield | 0.78% | 0.84% |
| FCF Payout Ratio | 34.4% | 21.9% |
Shares
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Shares Outstanding | 3,183,820 | 44,856,700 |
| Shares Change (QoQ) | -0.03% | 0.27% |
| Float | 3,139,840 | 36,934,400 |
| Shares Held by Insiders | 1.38% | 10.6% |
| Shares Held by Institutions | 72.8% | 63.5% |
Taxes
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Income Tax | $2.40M | $1.52M |
| Effective Tax Rate | 18.6% | 18.6% |
Scores
| Measure | Utah Medical Products | Industry median |
|---|---|---|
| Graham Number | $53.19 | $34.37 |
| Graham Upside | -28.7% | -58.3% |
| Altman Z-Score | 59.08 | 1.95 |
Calculated by StockData from Utah Medical Products's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.